Evidence-based Treatment Options in Cannabis Dependency

被引:15
|
作者
Walther, Lisa [1 ]
Gantner, Andreas [2 ]
Heinz, Andreas [1 ,3 ]
Majic, Tomislav [3 ]
机构
[1] Charite, Dept Psychiat & Psychotherapy, Campus Mitte, Berlin, Germany
[2] Therapieladen eV, Berlin, Germany
[3] Charite, St Hedwig Hosp, Dept Psychiat & Psychotherapy, Charite Campus Mitte, Berlin, Germany
来源
DEUTSCHES ARZTEBLATT INTERNATIONAL | 2016年 / 113卷 / 39期
关键词
RANDOMIZED CONTROLLED-TRIAL; MULTIDIMENSIONAL FAMILY-THERAPY; COGNITIVE-BEHAVIORAL THERAPY; PLACEBO-CONTROLLED TRIAL; STUDENT MARIJUANA USE; DOUBLE-BLIND; USE DISORDERS; TREATMENT PROGRAM; MOTIVATIONAL ENHANCEMENT; BRIEF INTERVENTION;
D O I
10.3238/arztebl.2016.0653
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Now that the consumption of natural and synthetic cannabinoids is becoming more widespread, the specific treatment of cannabis-related disturbances is an increasingly important matter. There are many therapeutic options, and it is not always clear which ones are evidence-based and appropriate for use in a given clinical situation. Methods: This review is based on reports of pertinent randomized and controlled trials (RCTs) that were retrieved by a selective search in the PubMed and Cochrane databases. Results: Cognitive behavior therapy (CBT) combined with other techniques has been found to have a moderate to large effect (Cohen's d = 0.53-0.9) on the amount of cannabis consumed as well as on the level of psychosocial functioning or the dependence syndrome. Systemic multidimensional family therapy (MDFT) has been found beneficial for younger adolescents who consume large amounts of cannabis and have psychiatric comorbidities. Short-term interventions with motivational talk therapy have been found effective for patients with or without an initial desire to achieve cannabis abstinence. All of these psychotherapeutic interventions are effective at evidence level Ia. The administration of gabapentin had a weak effect (d = 0.26) on the quantity consumed and on abstinence (evidence level Ib). Withdrawal symptoms can be alleviated with cannabinoid-receptor antagonists (d = 0.223 and 0.481) (evidence level Ib). On the other hand, there is evidence that serotonergic antidepressants can worsen withdrawal manifestations and increase the likelihood of relapse. Conclusion: Psychotherapeutic techniques remain the foundation of treatment for cannabis dependence. No drug has yet been approved for the treatment of cannabis dependence because of the lack of scientific evidence. The rates of abstinence that are currently achieved, even with psychotherapy, are still only moderate. Further clinical studies are needed for the evaluation of combinations of various treatments that can meet the needs of individual patients.
引用
收藏
页码:653 / +
页数:9
相关论文
共 50 条
  • [41] Evidence-Based Treatment for Pediatric Obsessive-Compulsive Disorder
    Brauer, Lindsay
    Lewin, Adam B.
    Storch, Eric A.
    ISRAEL JOURNAL OF PSYCHIATRY AND RELATED SCIENCES, 2011, 48 (04) : 280 - 287
  • [42] Evidence-Based Treatment of Post-Traumatic Stress Disorder
    Difede, JoAnn
    Olden, Megan
    Cukor, Judith
    ANNUAL REVIEW OF MEDICINE, VOL 65, 2014, 65 : 319 - 332
  • [43] Postpartum Hemorrhage: Evidence-based Medical Interventions for Prevention and Treatment
    Rajan, Priya V.
    Wing, Deborah A.
    CLINICAL OBSTETRICS AND GYNECOLOGY, 2010, 53 (01) : 165 - 181
  • [44] Canadian Guidelines for the Evidence-Based Treatment of Tic Disorders: Pharmacotherapy
    Pringsheim, Tamara
    Doja, Asif
    Gorman, Daniel
    McKinlay, Duncan
    Day, Lundy
    Billinghurst, Lori
    Carroll, Alan
    Dion, Yves
    Luscombe, Sandra
    Steeves, Thomas
    Sandor, Paul
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2012, 57 (03): : 133 - 143
  • [45] The evidence-based pharmacotherapy of social anxiety disorder
    Blanco, Carlos
    Bragdon, Laura B.
    Schneier, Franklin R.
    Liebowitz, Michael R.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2013, 16 (01) : 235 - 249
  • [46] Advancing psychotherapy and evidence-based psychological interventions
    Emmelkamp, Paul M. G.
    David, Daniel
    Beckers, Tom
    Muris, Peter
    Cuijpers, Pim
    Lutz, Wolfgang
    Andersson, Gerhard
    Araya, Ricardo
    Banos Rivera, Rosa M.
    Barkham, Michael
    Berking, Matthias
    Berger, Thomas
    Botella, Christina
    Carlbring, Per
    Colom, Francesc
    Essau, Cecilia
    Hermans, Dirk
    Hofmann, Stefan G.
    Knappe, Susanne
    Ollendick, Thomas H.
    Raes, Filip
    Rief, Winfried
    Riper, Heleen
    Van der Oord, Saskia
    Vervliet, Bram
    INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH, 2014, 23 : 58 - 91
  • [47] Reducing Harm Through Evidence-Based Alcohol Policies: Challenges and Options
    Giesbrecht, Norman
    Bosma, Linda M.
    Reisdorfer, Emilene
    WORLD MEDICAL & HEALTH POLICY, 2019, 11 (03): : 248 - 269
  • [48] Evidence-based pharmacotherapy of panic disorder: an update
    Batelaan, Neeltje M.
    Van Balkom, Anton J. L. M.
    Stein, Dan J.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 (03) : 403 - 415
  • [49] Evidence-Based Interventions for Cancer Treatment-Related Mucositis: Putting Evidence Into Practice
    Eilers, June
    Harris, Debra
    Henry, Karen
    Johnson, Lee Ann
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2014, 18 : 80 - 96
  • [50] Treatment of Restless Legs Syndrome: Evidence-Based Review and Implications for Clinical Practice (Revised 2017)
    Winkelmann, Juliane
    Allen, Richard P.
    Hoegl, Birgit
    Inoue, Yuichi
    Oertel, Wolfgang
    Salminen, Aaro V.
    Winkelman, John W.
    Trenkwalder, Claudia
    Sampaio, Cristina
    MOVEMENT DISORDERS, 2018, 33 (07) : 1077 - 1091